Multi-Omics Investigation of Innate Navitoclax Resistance in Triple-Negative Breast Cancer Cells

Marczyk, M; Patwardhan, GA; Zhao, J; Qu, RH; Li, XT; Wali, VB; Gupta, AK; Pillai, MM; Kluger, Y; Yan, Q; Hatzis, C; Pusztai, L; Gunasekharan, V

Pusztai, L (corresponding author), Yale Sch Med, Yale Canc Ctr, New Haven, CT 06511 USA.

CANCERS, 2020; 12 (9):

Abstract

Simple Summary Triple negative breast cancer is a disease with limited treatment options and the poorest outcome across all breast cancer subtypes, th......

Full Text Link